US EditionPublished • loading... • Updated
Dr Martens boot sales slow as fewer discounts deter shoppers
- On Tuesday, Dr Martens, the British bootmaker, said group revenues fell 3.1% to 253m in the third quarter ended 28 December 2025.
- Management scaled back discounts and clearance activity during Christmas trading as Dr Martens reprioritises profitability over revenue growth in its turnaround strategy.
- Direct-to-Consumer figures show sales fell 7% after reduced discounting, while wholesale channels in the UK and Germany rose 9.3%, and the currency impact is now estimated at �15 million.
- The company said it is comfortable meeting profit targets and forecasts significant pre-tax profit growth as Ije Nwokorie, chief executive, pledged to deliver all four strategic objectives for FY26.
- Dr Martens told shareholders it expects `broadly flat` revenues this year and said on Tuesday it has made `good progress` with its strategy.
Insights by Ground AI
15 Articles
15 Articles
Dr. Martens (LON:DOCS) Stock Price Down 11.6% – Time to Sell?
Dr. Martens plc (LON:DOCS – Get Free Report) was down 11.6% during mid-day trading on Tuesday . The stock traded as low as GBX 65 and last traded at GBX 66.90. Approximately 9,032,986 shares were traded during mid-day trading, an increase of 342% from the average daily volume of 2,043,681 shares. The stock had previously […]
Coverage Details
Total News Sources15
Leaning Left2Leaning Right0Center4Last UpdatedBias Distribution67% Center
Bias Distribution
- 67% of the sources are Center
67% Center
L 33%
C 67%
Factuality
To view factuality data please Upgrade to Premium
